TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Shyan Medicine AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
831
|
376 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
-5
|
9 | |
| EBITDA |
-5
|
9 | |
| Total assets |
65
|
95 | |
| Current assets |
65
|
95 | |
| Current liabilities |
2
|
1 | |
| Equity capital |
63
|
92 | |
| - share capital |
8
|
9 | |
| Employees (average) |
0
|
0
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
96.9%
|
96.8% | |
| Turnover per employee | 376 | ||
| Profit as a percentage of turnover |
-0.6%
|
2.4% | |
| Return on assets (ROA) |
-7.7%
|
9.5% | |
| Current ratio |
3250.0%
|
9500% | |
| Return on equity (ROE) |
-7.9%
|
9.8% | |
| Change turnover |
492
|
-3,940 | |
| Change turnover % |
167%
|
145%
|
-91% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.